This randomized controlled clinical trial will estimate the eradication efficacy of different
therapy for Helicobacter pylori treatment. The completion of this trial will expand new
therapy for the treatment of Helicobacter pylori, which can not only ensure clinical
efficacy, but also reduce the use of antibiotics.